Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3748/wjg.v21.i41.11567 http://scihub22266oqcxt.onion/10.3748/wjg.v21.i41.11567 C4631961!4631961 !26556987     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26556987 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26556987 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       World+J+Gastroenterol 2015 ; 21 (41 ): 11567-83 Nephropedia Template TP {{tp|p=26556987 |t=2015. Non-invasive diagnosis of liver fibrosis and cirrhosis |pdf=|usr=}}{{26556987 }} gab.com Text Non-invasive diagnosis of liver fibrosis and cirrhosis JO: World J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=26556987 #FOAvip The evaluation and follow up of liver fibrosis and cirrhosis have been traditionally performed by liver biopsy. However, during the last 20 years, it has become evident that this "gold-standard" is imperfect; even according to its proponents, it is only "the best" among available methods. Attempts at uncovering non-invasive diagnostic tools have yielded multiple scores, formulae, and imaging modalities. All are better tolerated, safer, more acceptable to the patient, and can be repeated essentially as often as required. Most are much less expensive than liver biopsy. Consequently, their use is growing, and in some countries the number of biopsies performed, at least for routine evaluation of hepatitis B and C, has declined sharply. However, the accuracy and diagnostic value of most, if not all, of these methods remains controversial. In this review for the practicing physician, we analyze established and novel biomarkers and physical techniques. We may be witnessing in recent years the beginning of the end of the first phase for the development of non-invasive markers. Early evidence suggests that they might be at least as good as liver biopsy. Novel experimental markers and imaging techniques could produce a dramatic change in diagnosis in the near future. Twit Text FOAVip Non-invasive diagnosis of liver fibrosis and cirrhosis ????World J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=26556987 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26556987 #FOAvip English Wikipedia <ref>{{Cite pmid|26556987 }}</ref> Non-invasive diagnosis of liver fibrosis and cirrhosis #MMPMID26556987 Lurie Y ; Webb M ; Cytter-Kuint R ; Shteingart S ; Lederkremer GZ World J Gastroenterol 2015[Nov]; 21 (41 ): 11567-83 PMID26556987 show ga The evaluation and follow up of liver fibrosis and cirrhosis have been traditionally performed by liver biopsy. However, during the last 20 years, it has become evident that this "gold-standard" is imperfect; even according to its proponents, it is only "the best" among available methods. Attempts at uncovering non-invasive diagnostic tools have yielded multiple scores, formulae, and imaging modalities. All are better tolerated, safer, more acceptable to the patient, and can be repeated essentially as often as required. Most are much less expensive than liver biopsy. Consequently, their use is growing, and in some countries the number of biopsies performed, at least for routine evaluation of hepatitis B and C, has declined sharply. However, the accuracy and diagnostic value of most, if not all, of these methods remains controversial. In this review for the practicing physician, we analyze established and novel biomarkers and physical techniques. We may be witnessing in recent years the beginning of the end of the first phase for the development of non-invasive markers. Early evidence suggests that they might be at least as good as liver biopsy. Novel experimental markers and imaging techniques could produce a dramatic change in diagnosis in the near future. |*Liver/diagnostic imaging/metabolism/pathology [MESH] |Biomarkers/blood [MESH] |Biopsy [MESH] |Diagnostic Imaging/*methods [MESH] |Elasticity Imaging Techniques [MESH] |Humans [MESH] |Liver Cirrhosis/blood/*diagnosis/diagnostic imaging/pathology [MESH] |Magnetic Resonance Imaging [MESH] |Magnetic Resonance Spectroscopy [MESH] |Predictive Value of Tests [MESH] |Prognosis [MESH] |Severity of Illness Index [MESH]Non-invasive diagnosis of liver fibrosis and cirrhosis (epmc).pdf DeepDyve Pubget Overpricing